相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathogenicity and virulence of African trypanosomes: From laboratory models to clinically relevant hosts
Liam J. J. Morrison et al.
VIRULENCE (2023)
An Update on African Trypanocide Pharmaceutics and Resistance
Keneth Iceland Kasozi et al.
FRONTIERS IN VETERINARY SCIENCE (2022)
Human African trypanosomiasis cases diagnosed in non-endemic countries (2011-2020)
Jose R. Franco et al.
PLOS NEGLECTED TROPICAL DISEASES (2022)
Nitro compounds against trypanosomatidae parasites: Heroes or villains?
Paulo Fernando da Silva Santos-Junior et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
Anti-trypanosomatid structure-based drug design - lessons learned from targeting the folate pathway
Joanna Panecka-Hofman et al.
EXPERT OPINION ON DRUG DISCOVERY (2022)
Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial
Victor Kande Betu Kumesu et al.
LANCET GLOBAL HEALTH (2022)
Systematic Review and Meta-Analysis on Human African Trypanocide Resistance
Keneth Iceland Kasozi et al.
PATHOGENS (2022)
Recent progress in diagnosis and treatment of Human African Trypanosomiasis has made the elimination of this disease a realistic target by 2030
Andres Alvarez-Rodriguez et al.
FRONTIERS IN MEDICINE (2022)
Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
Sonja Bernhard et al.
DISEASES (2022)
Immunoinformatic design of a putative multi-epitope vaccine candidate against Trypanosoma brucei gambiense
Ammar Usman Danazumi et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
Recent Advances in the Development of Broad-Spectrum Antiprotozoal Agents
Antonio Moreno-Herrera et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Evolving Differentiation in African Trypanosomes
Juan F. Quintana et al.
TRENDS IN PARASITOLOGY (2021)
Naphthoquinone derivatives exhibit apoptosis-like effect and anti-trypanosomal activity against Trypanosoma evansi
Ruma Rani et al.
VETERINARY PARASITOLOGY (2021)
Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases
Igor Jose dos Santos Nascimento et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
Naphthoquinones and Derivatives for Chemotherapy: Perspectives and Limitations of their Anti-trypanosomatids Activities
Luiza Dantas-Pereira et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors
Elany Barbosa da Silva et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Activity of Compounds from Temperate Propolis against Trypanosoma brucei and Leishmania mexicana
Adullah Alotaibi et al.
MOLECULES (2021)
The Trypanosome UDP-Glucose Pyrophosphorylase Is Imported by Piggybacking into Glycosomes, Where Unconventional Sugar Nucleotide Synthesis Takes Place
Oriana Villafraz et al.
MBIO (2021)
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
Victor Kande Betu Ku Mesu et al.
Lancet Global Health (2021)
Regulation of Antigenic Variation by Trypanosoma brucei Telomere Proteins Depends on Their Unique DNA Binding Activities
Bibo Li et al.
PATHOGENS (2021)
Structure, interdomain dynamics, and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes
Patrick Johe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Why hasn't there been more progress in new Chagas disease drug discovery?
Alane Beatriz Vermelho et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Flavonoid-derived Privileged Scaffolds in anti-Trypanosoma brucei Drug Discovery
Pone Kamdem Boniface et al.
CURRENT DRUG TARGETS (2019)
Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole
James A. Watson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
Victor Kande Betu Ku Mesu et al.
LANCET (2018)
Folates in Trypanosoma brucei: Achievements and Opportunities
Gregorio Cullia et al.
CHEMMEDCHEM (2018)
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors
Justin R. Harrison et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing
Daniela Begolo et al.
PLOS PATHOGENS (2018)
Proline Metabolism is Essential for Trypanosoma brucei brucei Survival in the Tsetse Vector
Brian S. Mantilla et al.
PLOS PATHOGENS (2017)
Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity
Claudiu T. Supuran
FUTURE MEDICINAL CHEMISTRY (2016)
Thiol redox biology of trypanosomatids and potential targets for chemotherapy
Alejandro E. Leroux et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2016)
RNA interference screen reveals a high proportion of mitochondrial proteins essential for correct cell cycle progress in Trypanosoma brucei
Diane-Ethna Mbang-Benet et al.
BMC GENOMICS (2015)
Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
Daniel Spinks et al.
CHEMMEDCHEM (2015)
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
LC-MS-based absolute metabolite quantification: application to metabolic flux measurement in trypanosomes
Dong-Hyun Kim et al.
METABOLOMICS (2015)
Genomic and Proteomic Studies on the Mode of Action of Oxaboroles against the African Trypanosome
Deuan C. Jones et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The unique chemistry of benzoxaboroles: Current and emerging applications in biotechnology and therapeutic treatments
C. Tony Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects
Stephen Patterson et al.
TRENDS IN PARASITOLOGY (2014)
Expression site attenuation mechanistically links antigenic variation and development in Trypanosoma brucei
Christopher Batram et al.
ELIFE (2014)
Inhibition of Rhodesain as a Novel Therapeutic Modality for Human African Trypanosomiasis
Roberta Ettari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Trypanocidal Activity of Marine Natural Products
Amy J. Jones et al.
MARINE DRUGS (2013)
Mathematical Modelling of Polyamine Metabolism in Bloodstream-Form Trypanosoma brucei: An Application to Drug Target Identification
Xu Gu et al.
PLOS ONE (2013)
Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase
Qing-Hua Hu et al.
SCIENTIFIC REPORTS (2013)
Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
Juma A. M. Ali et al.
MOLECULAR PHARMACOLOGY (2013)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Genotoxicity profile of fexinidazole-a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)
David Tweats et al.
MUTAGENESIS (2012)
Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
Belinda S. Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lipid metabolism in Trypanosoma brucei
Terry K. Smith et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2010)
Chagas disease: pushing through the pipeline
Julie Clayton
NATURE (2010)
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Julie A. Frearson et al.
NATURE (2010)
Lipidomic analysis of bloodstream and procyclic form Trypanosoma brucei
Gregory S. Richmond et al.
PARASITOLOGY (2010)
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
Isabel M. Vincent et al.
PLOS PATHOGENS (2010)
Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design
Iain D. Kerr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens
Kirk W. Deitsch et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
Shane R. Wilkinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development
Antonio Cavazzuti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cytokinesis in trypanosomatilds
Tansy C. Hammarton et al.
CURRENT OPINION IN MICROBIOLOGY (2007)
A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection
Patricia S. Doyle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis
O. Heby et al.
AMINO ACIDS (2007)
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site
Fernando L. Rock et al.
SCIENCE (2007)
Cell cycle regulation in Trypanosoma brucei
Tansy C. Hammarton
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2007)
The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2:: flagellar enzymes that are essential for parasite virulence
Michael Oberholzer et al.
FASEB JOURNAL (2007)
Adaptations in the lipid metabolism of the protozoan parasite Trypanosoma brucei
Jaap J. van Hellemond et al.
FEBS LETTERS (2006)
Antitrypanosomal and antileishmanial activities of flavonoids and their analogues:: In vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies
D Tasdemir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The genome of the kinetoplastid parasite, Leishmania major
AC Ivens et al.
SCIENCE (2005)
The genome of the African trypanosome Trypanosoma brucei
M Berriman et al.
SCIENCE (2005)
Trypanosome telomeres are protected by a homologue of mammalian TRF2
B Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites
HP Price et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
